All data are based on the daily closing price as of March 5, 2026
b

Boryung

003850.KO
6.48 USD
0.54
+9.09%

Overview

Last close
6.48 usd
Market cap
547.77M usd
52 week high
9.22 usd
52 week low
5.24 usd
Target price
8.88 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
0.7701
Price/Book Value
1.0272
Enterprise Value
678.42M usd
EV/Revenue
0.965
EV/EBITDA
8.3874

Key financials

Revenue TTM
703.06M usd
Gross Profit TTM
256.79M usd
EBITDA TTM
84.23M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
968.10M usd
Net debt
177.73M usd

About

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, and diabetes drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.
  • Symbol
    003850.KO
  • Exchange
    KO
  • Isin
    KR7003850005
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Jay Kim
  • Headquarter
    Seoul
  • Web site
    https://www.boryung.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top